E Fund Management Co., Ltd. Spectrum Pharmaceuticals Inc Transaction History

E Fund Management Co., Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.27 - $2.42 $48,501 - $92,419	-38,190 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.15 - $3.82 $29,833 - $53,006	13,876 Added 57.07%	38,190 $83,000
Q1 2021 May 12, 2021	BUY	$2.9 - $4.09 $70,510 - $99,444	24,314 New	24,314 $79,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.